Viewing Study NCT03842267


Ignite Creation Date: 2025-12-25 @ 12:53 AM
Ignite Modification Date: 2026-01-02 @ 7:14 AM
Study NCT ID: NCT03842267
Status: COMPLETED
Last Update Posted: 2023-03-10
First Post: 2019-02-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Evaluate the Efficacy and Safety of Gemigliptin in Type 2 Diabetes Who Have Inadequate GlycemIc Control With Dapagliflozin and Metformin (SOLUTION Study)
Sponsor: LG Chem
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module